Chong Kun Dang names new executives in shake-up

Published: 2010-01-06 06:57:00

Updated: 2010-01-06 06:57:00

Chong Kun Dang Pharmaceutical Co. said on January 1 that it has promoted Kim Young-eun (photo), a head of management board, as its vice chairman in a management reshuffle which involved several executives.

The leading drug maker also appointed seven executives who will serve in sales, marketin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK